Furthermore, using the systemic RNAi screening approach, Amin et al. (2018) identified a leucine-rich repeat kinase 2 (LRRK2) gene, which is often mutated in PD, and which shown to induce RIPK1-dependent apoptosis by activation of Complex I-associated RIPK1. This evidence concerns the gene LRRK2 and Parkinson disease.